Scleroderma en coup de sabre with central nervous system and ophthalmologic involvement: treatment of ocular symptoms with interferon gamma.

Scleroderma en coup de sabre, a variant of localized scleroderma, is a disorder of unknown origin characterized by fibrosis of connective tissue. Rare complications of scleroderma en coup de sabre are orbital and intracerebral involvement. We describe a patient with scleroderma en coup de sabre in whom intracerebral and orbital lesions developed after 2 decades of disease duration. Clinically, she had epilepsy, impaired vision, and retro-ocular pain of the affected eye. A 12-month course of interferon-gamma stopped progression of visual symptoms caused by orbital fibrous tissue. To our knowledge, this is the first patient with scleroderma en coup de sabre complicated by orbital involvement who was successfully treated with interferon-gamma.

[1]  V. N. Sehgal,et al.  En coup de sabre , 2002, International journal of dermatology.

[2]  R. Ruíz-Maldonado,et al.  Scleroderma ‘en coup de sabre’ and progressive facial hemiatrophy. Is it possible to differentiate them? , 2002, Journal of the European Academy of Dermatology and Venereology : JEADV.

[3]  M. Johnson,et al.  Scleroderma “en coup de sabre”: pathological evidence of intracerebral inflammation , 2001, Journal of neurology, neurosurgery, and psychiatry.

[4]  A. Franks,et al.  Scleroderma "en coup de sabre" , 2001 .

[5]  B. Dijkmans,et al.  Double-blind, placebo-controlled study of oral calcitriol for the treatment of localized and systemic scleroderma. , 2000, Journal of the American Academy of Dermatology.

[6]  T. Kanekura,et al.  Scleroderma en Coup de Sabre with Central Nervous System Involvement , 2000, The Journal of dermatology.

[7]  P. Itin,et al.  Double-Lined Frontoparietal Scleroderma en coup de sabre , 1999, Dermatology.

[8]  A. Silman,et al.  Interferon-alpha does not improve outcome at one year in patients with diffuse cutaneous scleroderma: results of a randomized, double-blind, placebo-controlled trial. , 1999, Arthritis and rheumatism.

[9]  Elst,et al.  Treatment of Linear Scleroderma with Oral 1,25‐Dihydroxyvitamin D3 (Calcitriol) in Seven Children , 1999, Pediatric dermatology.

[10]  Klein,et al.  Interferon‐gamma in the treatment of systemic sclerosis: a randomized controlled multicentre trial , 1998, The British journal of dermatology.

[11]  A. Paller,et al.  Topical calcipotriene for morphea/linear scleroderma. , 1998, Journal of the American Academy of Dermatology.

[12]  W. Gaus,et al.  Double-blind, placebo-controlled study of intralesional interferon gamma for the treatment of localized scleroderma. , 1997, Journal of the American Academy of Dermatology.

[13]  Bert H. van Bergen,et al.  D-Penizillamin in der Behandlung von Sklerodermie „en coup de sabre” , 1997, Der Hautarzt.

[14]  A. Baert,et al.  Linear scleroderma with orbital involvement: follow up and magnetic resonance imaging. , 1996, The British journal of ophthalmology.

[15]  M. Morrell,et al.  Intracerebral involvement in scleroderma en coup de sabre: Report of a case with neuropathologic findings , 1995, Annals of neurology.

[16]  T. Flotte,et al.  Interferons and collagen production. , 1990, The Journal of investigative dermatology.

[17]  Neldner Kh.  Treatment of localized linear scleroderma with phenytoin. , 1978 .

[18]  Thomas B. Fitzpatrick,et al.  Dermatology in general medicine , 1971 .